Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Immunocompromised Cas9 transgenic mice for rapid in vivo assessment of host factors involved in highly pathogenic virus infectionNicole Collette, Pragyesh Dhungel, Sean J Lund, et al.Development (Cambridge, England)|February 18, 2022
Notch signaling enhances bone regeneration in the zebrafish mandibleJessica M Kraus, Dion Giovannone, Renata Rydzik, et al.Mabs|January 3, 2024
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector functionJennifer L Schwedler, Maxwell A Stefan, Christine E Thatcher, et al.Protein Science : a Publication of the Protein Society|January 22, 2025
Combining computational modeling and experimental library screening to affinity-mature VEEV-neutralizing antibody F5Christopher A Sumner, Jennifer L Schwedler, Katherine Maia McCoy, et al.Mabs|August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodiesMaxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.Plos Pathogens|January 23, 2025
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodiesPeter R McIlroy, Le Thanh Mai Pham, Thomas Sheffield, et al.Frontiers in Immunology|January 21, 2026
An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse modelsZachary R Stromberg, Elvia E Silva, Sara C Johnston, et al.Pageof 1